LERCANIDIPINE BOUCHARA-RECORDATI 20 mg, film-coated tablet 90 tablets
Active ingredients: Lercanidipine hydrochloride, Lercanidipine
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LERCANIDIPINE BOUCHARA-RECORDATI 20 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 90 comprimé(s)
- Marketing authorisation holder
- BOUCHARA-RECORDATI
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Jan 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67688988CIP73924087CIP133400939240879Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LERCANIDIPINEcomprimé | 20 mg · un comprimé | SA |
| LERCANIDIPINEcomprimé | 18,8 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.